Scott T. Rottinghaus, Chief Medical Officer at Enanta Pharmaceuticals Inc. ($ENTA), made one open market sale of company shares in the last year, totaling $11,356. His most recent transaction occurred on December 5, 2025. Among 11,678 insiders with sales, his activity ranks 11,245th by value, well below the average of $8.6 million across 6.4 transactions per insider. Rottinghaus reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | F | Common Stock | 3413 | $14.25 | 25,254.0000 | 29,019,344 | 11.91% | 0.01% |
| Feb. 12, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | A | Common Stock | 5225 | $0.00 | 28,667.0000 | 29,019,344 | 22.29% | 0.02% |
| Feb. 12, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | A | Common Stock | 1650 | $0.00 | 23,442.0000 | 29,019,344 | 7.57% | 0.01% |
| Dec. 5, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | S | Common Stock | 798 | $14.23 | 21,792.0000 | 28,862,601 | 3.53% | 0.00% |
| Nov. 25, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | A | Stock Option (right to buy) | 110000 | $0.00 | 110,000.0000 | 28,862,601 | 9999.99% | 0.38% |
| Aug. 8, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | F | Common Stock | 2217 | $6.99 | 22,590.0000 | 21,377,923 | 8.94% | 0.01% |
| Feb. 12, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | A | Common Stock | 9750 | $0.00 | 27,668.0000 | 0 | 54.41% | 0.00% |
| Feb. 12, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | F | Common Stock | 2861 | $5.59 | 24,807.0000 | 0 | 10.34% | 0.00% |
| Dec. 6, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | S | Common Stock | 866 | $8.06 | 17,918.0000 | 0 | 4.61% | 0.00% |
| Nov. 27, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | A | Stock Option (right to buy) | 87000 | $0.00 | 87,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 8, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | F | Common Stock | 1466 | $12.73 | 18,784.0000 | 0 | 7.24% | 0.00% |
| Aug. 8, 2023 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | F | Common Stock | 1467 | $17.23 | 25,533.0000 | 0 | 5.43% | 0.00% |
| July 15, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | S | Common Stock | 5375 | $17.08 | 21,717.0000 | 0 | 19.84% | 0.00% |
| July 12, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | S | Common Stock | 2271 | $15.04 | 21,717.0000 | 0 | 9.47% | 0.00% |
| July 15, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | M | Stock Option (Right to Buy) | 5375 | $0.00 | 80,625.0000 | 0 | 6.25% | 0.00% |
| July 11, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | S | Common Stock | 4299 | $15.07 | 23,988.0000 | 0 | 15.20% | 0.00% |
| July 15, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | M | Common Stock | 5375 | $8.99 | 27,092.0000 | 0 | 24.75% | 0.00% |
| Feb. 12, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | F | Common Stock | 755 | $12.41 | 28,287.0000 | 0 | 2.60% | 0.00% |
| Feb. 12, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Rottinghaus Scott T. | Chief Medical Officer | A | Common Stock | 2576 | $0.00 | 29,042.0000 | 0 | 9.73% | 0.00% |